Francisco Navarro
About Francisco Navarro
Francisco Navarro is a Principal Scientist at SalioGen Therapeutics with extensive experience in molecular and cell biology, immunology, and gene editing. He has held various scientific roles at prominent institutions, including Harvard Medical School and the Salk Institute for Biological Studies.
Current Role at SalioGen Therapeutics
Francisco Navarro serves as Principal Scientist at SalioGen Therapeutics since 2021. In this role, he contributes to the development of innovative therapeutic solutions, leveraging his extensive background in molecular and cell biology. His responsibilities include leading research initiatives and collaborating with cross-functional teams to align with corporate goals.
Previous Experience at Salk Institute for Biological Studies
Navarro worked as a Postdoctoral Research Fellow at the Salk Institute for Biological Studies from 2001 to 2004. During his three years in San Diego, California, he engaged in advanced research projects that contributed to the understanding of biological processes, enhancing his expertise in the field.
Professional Background in Immunotherapy and Gene Editing
Navarro has held various positions in the biotechnology sector, including Scientist roles at Rubius Therapeutics and NantKwest. He worked at Rubius Therapeutics from 2014 to 2015 and then at NantKwest from 2015 to 2018. His experience includes significant contributions to immunotherapy and gene editing, showcasing his ability to support pre-clinical development of engineered NK and T cell therapies.
Educational Qualifications in Biological Sciences and Immunology
Francisco Navarro obtained his Bachelor's degree in Biological Sciences from Universidad Complutense de Madrid. He furthered his education at Universidad Autónoma de Madrid, where he earned a Doctor of Philosophy (PhD) in Immunology. This academic foundation supports his extensive scientific expertise and research capabilities.
Experience in Academia and Mentorship
Navarro served as an Instructor in Pediatrics at Harvard Medical School from 2004 to 2014, where he contributed to academic research and education. He has extensive experience managing and mentoring junior scientists, demonstrating his commitment to fostering talent and collaboration in scientific research.